मैट्रिक्स
 
 
सिंकॉम फॉर्मुलेशंस > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का सिंकॉम फॉर्मुलेशंस - बीएसई: 524470, NSE: N.A

सिंकॉम फॉर्मुलेशंस

बीएसई: 524470  |  NSE: N.A  |  ISIN: INE312C01025  |  Pharmaceuticals

कंपनी इतिहास - सिंकॉम फॉर्मुलेशंस
1988 
 
 -Syncom Formulation (India) Ltd. was established.
 
 2005 
 
 -Company had allotted 2.65lakh fully paid-up equity shares of Rs 10
 each at a premium of Rs 80 per share on the preferential basis.
 
 2006 
 
 -Board of directors of the company had considered issue of 2.95
 equity shares aggregating to Rs 1.59 crore on preferential basis.
 
 -The comapny approved an Rs 7.1 crore plan to install two wind mills
 of 0.60 MW each at Sangli in Maharashtra.
 
 2008 
 -Board of directors of the company had approved amendment in the
 Articles of Association for insertion of clauses relating to
 authorizing the board for issuance of warrants convertible into
 equity shares of the company.
 
 -On 25th March 2008, board of directors of the company had transacted
 the allotment of 3.1 lakh equity shares of Rs 10 each by way of
 preferential allotment at a premium of Rs 36per equity share to Shri.
 Kedarmal Bankda, promoter of the company.
 
 -On the same date board of directors of the company had transacted
 the allotment of 3.25 lakh warrants of Rs 46 each.
 
 2009
 
 -Syncom Formulations India has recommended the dividend @ Rs. 0.50
 (5%) on equity shares of Rs. 10/- each
 
 -Syncom Formulation (India) Ltd Issues Rights in the Ratio of 1:2
 
 2011
 
 -Mrs. Shikha Sethi, has been appointed as the Company secretary of
 the Company
 
 2012
 
 -Company has incorporated a Wholly Owned Subsidiary Company in the
 name of TRADE ZONE FZE in the United Arab Emirates
 
 -Shri. Praveen Jindal has been appointed as an Independent Director
 of the company.
 
 2013
 
 -The Company in the proportion of 5 (Five) Equity Shares of Rs. 1
 (Rs. One) for every 2 (Two) Equity Shares of Rs. 1 (Rs. One) held by
 them on the record date as may be decided by the Board with the
 consultation of the Stock Exchange.
 -The Company has recommend a dividend Rs. 0.60 (Sixty paise) (6%) per
 equity share of Rs. 10/- each for the year 2012-13,
 -Syncom Formulation (India) has announces bonus in the ratio of 5:2
 -Syncom Formulation (India) has splits its face value from Rs 10/- to
 1/-
                                                                      
                                                           
 2014
 
 -The Company has recommend a dividend of Rs. 0.02 (Two paise) (2%)
 per equity share of Re. 1/- each for the year 2013-14
 -The Company has appointed Smt. Rinki Bankda in the category of Women
 Director as an Additional Director of the Company w.e.f. August 13,
 2014
 
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • BREAKING NEWS LOWER : कंसो मुनाफा `548.2 Cr से बढ़कर `2,647 Cr(YoY)
  • BREAKING NEWS LOWER : कंसो आय `18,492 Cr से घटकर `16,171 Cr (YoY)
  • BREAKING NEWS LOWER : कंसो EBITDA `2,221.8 Cr से बढ़कर `6,453.1 Cr
  • BREAKING NEWS LOWER : कंसो EBITDA मार्जिन 12% से बढ़कर 39.9% (YoY)

अभी देखें

टेक गुरु

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.